← All organizations
Leidos
For profitWebsite ↗
Also known as: Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., USA | Leidos | Leidos Biomedical Research, Inc. | Leidos Biomedical Research, Inc. in support of Clinical Research Section, LIR, NIAID, Natinal Institutes of Health | Leidos Biomedical Research, Inc. in support of Laboratory of Immunoregulation, NIAID, NIH | Leidos, Inc. | Leidos Life Sciences
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2010Last known activity
Jun 15, 2024
Timeline
1960s
- Jun 1, 1969
Leidos— Founded
Drugs by trial phase (21 distinct, 13 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Studied for
- Alphavirus Infections
- Chikungunya Fever
- Communicable Diseases
- Encephalitis
- Encephalomyelitis, Eastern Equine
- Encephalomyelitis, Equine
- Encephalomyelitis, Venezuelan Equine
- Encephalomyelitis, Western Equine
- Flaviviridae Infections
- Flavivirus Infections
- Hemorrhagic Fever, Ebola
- Hemorrhagic Fevers, Viral
- HIV Infections
- Infections
- Influenza, Human
- RNA Virus Infections
- Uterine Cervical Neoplasms
- Virus Diseases
- Zika Virus Infection
Recent trials (16)
- NCT06274853CollaboratorPhase 1Jun 15, 2024
- NCT05111353CollaboratorPhase 1Dec 31, 2021
- NCT05085574Study directorPhase 2Oct 31, 2021
- NCT05077969Study directorPhase 2Oct 31, 2021
- NCT05077969Lead sponsorPhase 2Oct 31, 2021
- NCT05077332Study directorPhase 2Oct 31, 2021
- NCT05077332Lead sponsorPhase 2Oct 31, 2021
- NCT05085574Lead sponsorPhase 2Oct 31, 2021
- NCT04508309CollaboratorPhase 3Dec 31, 2020
- NCT04301154CollaboratorPhase 1Jun 30, 2020
- NCT03879603CollaboratorPhase 1Mar 29, 2019
- NCT03110770CollaboratorPhase 2Mar 29, 2017
- NCT02562482CollaboratorPhase 2Oct 1, 2015
- NCT02267109CollaboratorPhase 1Oct 1, 2014
- NCT01052480Study chairPhase 2Dec 1, 2010
Details
- Founded
- Reston, VA, US Jun 1, 1969
- Last known activity
- Jun 15, 2024
Notes
--- Notes from Leidos Biomedical Research, Inc.: CRO ---